BioSpace News Archive

Press Releases

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

April 9, 2026
·
8 min read
Press Releases

C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)

April 9, 2026
·
6 min read
Press Releases

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

April 9, 2026
·
5 min read
Press Releases

Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155

April 9, 2026
·
8 min read
Press Releases

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

April 9, 2026
·
7 min read
Press Releases

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

April 9, 2026
·
8 min read
Press Releases

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

April 9, 2026
·
5 min read
Press Releases

Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant

April 9, 2026
·
3 min read
Press Releases

Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU

April 9, 2026
·
4 min read
Press Releases

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

April 9, 2026
·
6 min read